Joseph Fraietta, an immunologist at the University of Pennsylvania in Philadelphia, agrees. In his own experience with CRISPR, he says, his group can edit only about three genes in CAR T cells at a time before the cells become unhealthy. This will open more avenues, he says. But he cautions that t